Psychotherapy for people with HIV and PTSD
Pilot Feasibility Proposal to Adapt Trauma-focused Psychodynamic Psychotherapy (TFPP) for PLWH and PTSD
NA · Montefiore Medical Center · NCT05929911
This study is testing a new type of therapy for people living with HIV and PTSD to see if it helps them feel better and improve their health.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Montefiore Medical Center (other) |
| Locations | 1 site (The Bronx, New York) |
| Trial ID | NCT05929911 on ClinicalTrials.gov |
What this trial studies
This pilot study focuses on individuals living with HIV who also have post-traumatic stress disorder (PTSD). It adapts a non-exposure based psychotherapy that emphasizes emotional reflection and relationship dynamics to address the unique needs of this population. The study aims to assess the acceptability and effectiveness of this treatment while exploring the connections between HIV-related health factors and PTSD. By understanding these relationships, the research seeks to improve health outcomes for participants.
Who should consider this trial
Good fit: Ideal candidates include individuals diagnosed with PTSD and HIV who have stable psychiatric medication management.
Not a fit: Patients with acute suicidality, psychosis, or unstable medical conditions unrelated to HIV may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly improve the mental health and overall well-being of patients living with HIV and PTSD.
How similar studies have performed: While there is limited research specifically on this approach for PLWH, similar psychotherapeutic interventions have shown promise in treating PTSD in other populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of DSM-5 defined PTSD, per the Clinician Administered PTSD Scale \& CAPS-5 total severity score greater than or equal to 25 * HIV diagnosis (by medical records or HIV testing) * Stable psychiatric/psychotropic medication for \>=2 months and ongoing during treatment Exclusion Criteria: * Psychosis * Bipolar I * Acute suicidality * Current substance use disorder * Organic mental syndrome or intellectual disability * Unstable non-HIV medical conditions
Where this trial is running
The Bronx, New York
- Albert Einstein College of Medicine — The Bronx, New York, United States (RECRUITING)
Study contacts
- Principal investigator: Barbara Milrod, MD — Montefiore Medical Center
- Study coordinator: John R Keefe, PhD
- Email: john.keefe@einsteinmed.edu
- Phone: 703-981-7184
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Post Traumatic Stress Disorder, HIV, PTSD, psychotherapy, trauma